KDM2B controls HIF levels and activity through its JmjC and CxxC domains

This study demonstrates that KDM2B acts as a cell type-dependent regulator of HIF-1 expression and activity through its JmjC and CxxC domains, thereby facilitating RNA Pol II recruitment and supporting cellular proliferation under hypoxic conditions.

The Gist

Imagine your body is a bustling city. When the oxygen supply gets cut off (a situation scientists call hypoxia), the city needs an emergency manager to keep things running. This manager is a protein called HIF-1α. Its job is to flip the switches on genes that help cells survive without enough air—like turning on emergency generators (metabolism) or building new roads for blood flow (angiogenesis).

For a long time, scientists knew how HIF-1α was protected from being destroyed when oxygen was low. But they didn't fully understand how the city built the manager in the first place.

This paper introduces a new character: KDM2B. Think of KDM2B as the foreman or the construction site manager who is responsible for getting the HIF-1α manager built and ready for work.

Here is the story of what the researchers found, broken down into simple concepts:

1. The Foreman is Essential (But Picky)

The researchers tested this "foreman" (KDM2B) in different types of city cells (U2OS, MDA-MB-231, and HeLa).

• In most cities (U2OS and MDA-MB-231): When they removed the foreman (KDM2B), the construction of the emergency manager (HIF-1α) stopped. The city couldn't adapt to the low oxygen, and the workers (cells) started to die.
• In one specific city (HeLa): Interestingly, removing the foreman actually made the emergency manager more active. This shows that KDM2B's job depends on the specific neighborhood (cell type) it's working in.

2. How the Foreman Works: The Two Tools

KDM2B is a complex machine with several tools attached to it. The researchers wanted to know which tools were actually doing the work. They found that KDM2B needs two specific tools to build HIF-1α:

• The DNA-Grabber (CxxC Domain): This is like a pair of hands that grabs onto the blueprints (DNA) to hold them in place.
• The Chemical Eraser (JmjC Domain): This is like a specialized eraser that removes chemical "sticky notes" (methyl groups) from the DNA, making the blueprint easier to read.

The Discovery: If you break either of these two tools, the foreman becomes useless. It can't build the HIF-1α manager anymore. However, the other tools KDM2B carries (like the F-Box or PHD domains) turned out to be irrelevant for this specific job.

3. The Construction Site Mechanism

How does KDM2B actually get the job done?

• Recruiting the Crew: The researchers found that KDM2B acts like a recruiter. It goes to the construction site (the HIF-1α gene) and calls in the RNA Polymerase II crew. You can think of RNA Polymerase II as the construction crew that actually reads the blueprints and builds the protein.
• The Result: Without KDM2B, the construction crew never shows up. No crew means no blueprints are read, which means no HIF-1α manager is built. Without the manager, the cell doesn't know how to survive the lack of oxygen.

4. The Big Picture: Survival and Cancer

Why does this matter?

• Survival: Cells need KDM2B to survive when oxygen is low. If you take away KDM2B, the cells panic and stop dividing or even die, because they can't turn on their emergency survival systems.
• Cancer Connection: Cancer cells are like rogue cities that love low-oxygen environments (tumors often have poor blood flow). They rely heavily on HIF-1α to grow and spread. Since KDM2B is the foreman that helps build HIF-1α, cancer cells need KDM2B to survive.
  • The data showed that in many human cancers, when KDM2B levels are high, HIF-1α levels are also high.
  • This suggests that if we could develop drugs to stop KDM2B (stop the foreman), we might be able to starve cancer cells of their emergency manager, causing them to die.

Summary Analogy

Imagine a power outage in a city.

• HIF-1α is the Emergency Power Plant Manager.
• KDM2B is the Foreman who ensures the Manager is hired and the power plant is built.
• The JmjC and CxxC domains are the Foreman's Hard Hat and Clipboard. Without them, the Foreman can't do his job.
• RNA Polymerase II is the Construction Crew that builds the plant.

The paper tells us that if you fire the Foreman (KDM2B) or break his tools, the Emergency Power Plant Manager never gets hired. The city (the cell) is left in the dark and eventually shuts down. This is a crucial discovery for understanding how cells survive stress and how we might treat diseases like cancer.

Technical Summary

1. Problem Statement

Hypoxia-Inducible Factors (HIFs) are master regulators of cellular adaptation to low oxygen, controlling genes involved in metabolism, angiogenesis, and survival. While the post-translational regulation of HIF-1$\alpha$ by prolyl hydroxylases (PHDs) and the Von Hippel-Lindau (VHL) complex is well-established, the transcriptional regulation of HIF1A and the modulation of HIF activity by chromatin modifiers remain less understood.

KDM2B (Lysine Demethylase 2B) is a JmjC domain-containing protein known to be a direct target of HIF-1$\alpha$ and is dysregulated in various cancers. However, its specific role in regulating the HIF pathway itself—whether it acts as a feedback inhibitor, a co-activator, or has no effect—was previously unclear. This study aims to elucidate the functional relationship between KDM2B and the HIF pathway, determining if KDM2B regulates HIF-1$\alpha$ expression and activity, and identifying the specific protein domains responsible for this regulation.

2. Methodology

The researchers employed a multi-faceted approach using human cancer cell lines (U2OS, MDA-MB-231, HeLa, and HEK293) to investigate KDM2B's role:

• Genetic Manipulation:
  • Loss-of-Function: KDM2B was depleted using two distinct siRNAs (KDM2B_1 and KDM2B_2).
  • Gain-of-Function: Cells were transfected with wild-type (WT) KDM2B plasmids or plasmids containing specific loss-of-function mutations in key domains: JmjC (demethylase), CxxC (DNA binding), PHD (chromatin reader), and F-box (ubiquitin ligase component).
• Hypoxia Models: Cells were exposed to 1% O$_2$ for 24 hours to induce hypoxia, compared against normoxic (21% O$_2$) controls.
• Functional Assays:
  • Luciferase Reporter Assays: Used HRE-luciferase (Hypoxia Response Element) and NF-$\kappa$B-luciferase reporters to measure transcriptional activity.
  • Immunoblotting: Quantified protein levels of HIF-1$\alpha$, HIF-2$\alpha$, HIF-1$\beta$, and HIF target genes (CA9, BNIP3, BNIP3L).
  • qPCR: Measured mRNA levels of HIF1A, HIF2A, and KDM2B.
  • Chromatin Immunoprecipitation (ChIP)-qPCR: Analyzed the recruitment of HIF-1$\alpha$ to target gene promoters (HREs) and RNA Polymerase II (RNA Pol II) to the HIF1A promoter.
  • Cell Proliferation: Measured cell counts over 96 hours under normoxic and hypoxic conditions.
• Bioinformatics: Correlation analysis between KDM2B and HIF1A mRNA expression was performed using The Cancer Genome Atlas (TCGA) datasets via GEPIA2.

3. Key Contributions and Results

A. KDM2B is a Positive Regulator of HIF Activity (Cell-Type Dependent)

• Depletion Effects: In U2OS and MDA-MB-231 cells, KDM2B depletion significantly reduced HIF-dependent luciferase activity and the protein levels of HIF target genes (CA9, BNIP3, BNIP3L) under hypoxia.
• HeLa Anomaly: Interestingly, in HeLa cells, KDM2B depletion increased HIF activity, suggesting a cell-type-specific regulatory mechanism.
• Overexpression Effects: Conversely, overexpression of KDM2B in U2OS and HEK293 cells significantly enhanced HIF activity and HIF-1$\alpha$ protein levels, even under normoxic conditions.

B. Regulation of HIF-1$\alpha$ at the Transcriptional Level

• Protein and mRNA Levels: KDM2B depletion led to a reduction in both HIF-1$\alpha$ protein and HIF1A mRNA levels in U2OS and MDA-MB-231 cells. This indicates KDM2B regulates HIF-1$\alpha$ abundance via transcriptional control, not just post-translational stability.
• Promoter Recruitment: ChIP-qPCR revealed that KDM2B depletion reduced the recruitment of RNA Polymerase II to the HIF1A promoter. This suggests KDM2B facilitates the initiation of HIF1A transcription.

C. Mechanistic Requirement of Specific Domains

The study dissected the functional domains of KDM2B required for HIF regulation:

• Essential Domains: The JmjC (demethylase) and CxxC (DNA-binding) domains were strictly required. Mutants lacking these functions failed to increase HIF activity or HIF-1$\alpha$ levels upon overexpression.
• Non-Essential Domains: Mutations in the PHD (Plant Homeodomain) and F-box domains did not impair KDM2B's ability to regulate HIF, indicating these functions are dispensable for this specific pathway.
• NF-$\kappa$B Link: The study also found that KDM2B positively regulates NF-$\kappa$B activity (via JmjC and CxxC domains), suggesting a potential indirect mechanism where KDM2B supports HIF-1$\alpha$ expression through NF-$\kappa$B signaling, a known regulator of HIF1A.

D. Biological Consequences on Cell Survival

• Proliferation: KDM2B depletion significantly impaired cell proliferation in both normoxia and hypoxia.
• Hypoxic Survival: Under hypoxic conditions, KDM2B-depleted cells showed a drastic reduction in cell numbers, often dropping below the initial seeding density, suggesting increased cell death. This correlates with the reduced expression of survival genes like BNIP3 and BNIP3L.

E. Clinical Correlation

• Analysis of TCGA data revealed a statistically significant, moderate positive correlation (0.3–0.5) between KDM2B and HIF1A mRNA levels across multiple human cancer types, supporting the physiological relevance of these findings in human pathology.

4. Significance

This study establishes a novel, positive feedback loop in the hypoxia response pathway:

1. New Regulatory Layer: It identifies KDM2B as a critical transcriptional activator of HIF1A, adding a layer of regulation beyond the canonical PHD/VHL degradation pathway.
2. Mechanistic Insight: It demonstrates that KDM2B's demethylase activity (JmjC) and DNA-binding capability (CxxC) are essential for recruiting RNA Pol II to the HIF1A promoter.
3. Therapeutic Implications: Given the role of HIF in cancer progression and the link between KDM2B and cell survival in hypoxia, KDM2B inhibitors could potentially suppress HIF signaling in tumors. Conversely, in conditions like neurodegeneration where HIF-mediated survival is protective, KDM2B inhibition might be detrimental.
4. Developmental Context: The findings align with previous observations that KDM2B knockout embryos lack vasculature (a HIF-dependent process), reinforcing KDM2B's role in angiogenesis and development.

In summary, KDM2B acts as a crucial epigenetic regulator that ensures sufficient HIF-1$\alpha$ expression to allow cells to adapt and survive under low-oxygen stress, functioning through its catalytic and DNA-binding domains.